Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis

Updated research nosology for HIV-associated neurocognitive disorders

Andrea Antinori, Gabriele Arendt, James T. Becker et al. · Neurology · 2007 · 2.6K citations

Medicine, Neurology, Neuroscience +14

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

Robert K. Heaton, David B. Clifford, Donald Franklin et al. · Neurology · 2010 · 2.3K citations · Full text

Medicine, Neurology, Psychiatry +17

Mortality in the Highly Active Antiretroviral Therapy Era

Frank J. Palella, Rose Baker, Anne C. Moorman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 1.4K citations

Public Health, Infectious Diseases, Epidemiologic Methods +15

 -D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Gloria Mattiuzzi, E Estey, Hagop M. Kantarjian et al. · Clinical Infectious Diseases · 2004 · 644 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Predictive Validity of Global Deficit Scores in Detecting Neuropsychological Impairment in HIV Infection

Catherine L. Carey, Steven Paul Woods, Raúl González et al. · Journal of Clinical and Experimental Neuropsychology · 2004 · 552 citations

Social Sciences, Psychiatry, Psychology +17